Vialwirebiotech, curated
November 21, 2026, 8:30 AM
October 31, 2026
- 7:02 AM · Ars Technica — Science7:02 AMThe FDA wants to pull its approval of a drug. It’s not so easy. — Ars Technica — Science
October 30, 2026
- 5:33 PM · Bloomberg — Technology5:33 PMIllumina CEO on Q3 Results and Business Outlook — Bloomberg — Technology
- 12:38 PM · Pharmaceutical Technology12:38 PMIDWeek 2026: early ensitrelvir PEP may benefit breakthrough and established Covid-19 — Pharmaceutical Technology
- 12:28 PM · Pharmaceutical Technology12:28 PMIDWeek 2026: ISL/LEN on track to become the first once-weekly oral HIV therapy — Pharmaceutical Technology
- 12:00 PM · BioWorld12:00 PMAcumen’s Alzheimer’s drug fails in phase II; stock plummets — BioWorld
- 12:00 PM · BioWorld12:00 PMBambusa, Aspen join biopharma’s IPO parade — BioWorld
- 10:28 AM · Bloomberg — Technology10:28 AMAstraZeneca CFO on AI, Earnings, Restructuring Plan — Bloomberg — Technology
- 10:26 AM · Pharmaceutical Technology10:26 AMPrediction markets herald insider trading risks for private biotechs — Pharmaceutical Technology
- 10:00 AM · PharmaVoice10:00 AMKeytruda biosims are coming — but they face an uphill battle — PharmaVoice